Tremor secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
You can view and copy the source of this page.
__NOTOC__
__NOTOC__
{{Xyz}}
{{Tremor}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{ZMalik}}


==Overview==
==Overview==
There are no established measures for the secondary prevention of [disease name].
Effective measures for the [[secondary prevention]] of tremor varies according to the cause of tremor.
 
OR
 
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].


==Secondary Prevention==
==Secondary Prevention==
 
*Effective measures for the [[secondary prevention]] of tremor varies according to the cause of tremor.
Effective measures for the secondary prevention of [[Parkinson's disease]] include<ref name="pmid31706021">{{cite journal| author=Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G| title=Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest? | journal=Neurobiol Dis | year= 2020 | volume= 134 | issue=  | pages= 104671 | pmid=31706021 | doi=10.1016/j.nbd.2019.104671 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31706021  }} </ref>:
*Enhanced physiologic tremor and [[drug]] induced tremor can get better by avoiding tremor stimulating factors or [[drugs]] respectively.
*[[Caffeine]] intake
*[[Essential]] tremor and [[Parkinson's disease]] worsen with time, there has been no identified measure for [[secondary prevention]] of these causes, however some improvement has been seen in [[Parkinson's disease]] with [[caffeine]] intake and physical activity<ref name="pmid31706021">{{cite journal| author=Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G| title=Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest? | journal=Neurobiol Dis | year= 2020 | volume= 134 | issue=  | pages= 104671 | pmid=31706021 | doi=10.1016/j.nbd.2019.104671 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31706021  }} </ref>.
*[[Physical activity]]


==References==
==References==

Latest revision as of 04:07, 1 February 2021

Tremor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tremor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tremor secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tremor secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tremor secondary prevention

CDC on Tremor secondary prevention

Tremor secondary prevention in the news

Blogs on Tremor secondary prevention

Directions to Hospitals Treating Tremor

Risk calculators and risk factors for Tremor secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

Overview

Effective measures for the secondary prevention of tremor varies according to the cause of tremor.

Secondary Prevention

References

  1. Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G (2020). "Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?". Neurobiol Dis. 134: 104671. doi:10.1016/j.nbd.2019.104671. PMID 31706021.

Template:WH Template:WS